Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines

Neuroscience Research

Volumn 56, Issue 1, 2006, Pages 2-13

  Nawa, Hiroyuki ^a   Takei, Nori ^b,c  

^a NIIGATA UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amniotic fluid; EGF; ErbB1; IL 1; Obstetric complication; Psychiatric disease; Viral infection

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; NEU DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BRAIN INFECTION; BRAIN INJURY; CHROMOSOME ANALYSIS; COGNITIVE DEFECT; CYTOKINE PRODUCTION; DISEASE MODEL; DOPAMINERGIC NERVE CELL; FUNCTIONAL PROTEOMICS; GABAERGIC SYSTEM; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCHIZOPHRENIA; SYNAPSE;

ANIMALS; BEHAVIOR; COGNITION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FETUS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 33748616003     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.06.002     Document Type: Review

References (178)

1. Abreu P., Llorente E., Hernandez M.M., and Gonzalez M.C. Interleukin-1 beta stimulates tyrosine hydroxylase activity in the median eminence. Neuroreport 5 (1994) 1356-1358
2. Ackerman IV W.E., Rovin B.H., and Kniss D.A. Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells. Biol. Reprod. 71 (2004) 2079-2086
3. Adams W., Kendell R.E., Hare E.H., and Munk-Jorgensen P. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Br. J. Psychiatry 163 (1993) 522-534
4. Adinolfi M., Beck S.E., Haddad S.A., and Seller M.J. Permeability of the blood-cerebrospinal fluid barrier to plasma proteins during foetal and perinatal life. Nature 259 (1976) 140-141
5. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
6. Akiyama K. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr. Res. 37 (1999) 97-106
7. Aleman A., Kahn R.S., and Selten J.P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry 60 (2003) 565-571
8. Allan S.M., Tyrrell P.J., and Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5 (2005) 629-640
9. Andreasen N., Nasrallah H.A., Dunn V., Olson S.C., Grove W.M., Ehrhardt J.C., Coffman J.A., and Crossett J.H. Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Arch. Gen. Psychiatry 43 (1986) 136-144
10. Anisman H., and Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 35 (2003) 2-11
11. Anisman H., Merali Z., and Hayley S. Sensitization associated with stressors and cytokine treatments. Brain Behav. Immun. 17 (2003) 86-93
12. Anttila S., Illi A., Kampman O., Mattila K.M., Lehtimaki T., and Leinonen E. Association of EGF polymorphism with schizophrenia in Finnish men. Neuroreport 15 (2004) 1215-1218
13. Arnold S.E., and Trojanowski J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. (Berl.) 92 (1996) 217-231
14. Banks W.A., Farr S.A., and Morley J.E. Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 10 (2002-2003) 319-327
15. Bayer S.A., Altman J., Russo R.J., and Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14 (1993) 83-144
16. Bayer T.A., Buslei R., Havas L., and Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 271 (1999) 126-128
17. Beraki S., Aronsson F., Karlsson H., Ogren S.O., and Kristensson K. Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol. Psychiatry 10 (2005) 299-308
18. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., and Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 25 (2005) 8000-8009
19. Bjelke B., Andersson K., Ogren S.O., and Bolme P. Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission. Brain Res. 543 (1991) 1-9
20. Boin F., Zanardini R., Pioli R., Altamura C.A., Maes M., and Gennarelli M. Association between-G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol. Psychiatry 6 (2001) 79-82
21. Boksa P., Zhang Y., and Bestawros A. Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences. Exp. Neurol. 175 (2002) 388-397
22. Boksa P., and El-Khodor B.F. Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci. Biobehav. Rev. 27 (2003) 91-101
23. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., and Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002) 204-215
24. Boulanger L.M., and Shatz C.J. Immune signalling in neural development, synaptic plasticity and disease. Nat. Rev. Neurosci. 5 (2004) 521-531
25. Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch. Gen. Psychiatry 47 (1990) 181-188
26. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl.) 156 (2001) 234-258
27. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., and Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61 (2004) 774-780
28. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., and Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 58 (2001) 1032-1037
29. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Wagner R.L., and Yolken R.H. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav. Immun. 15 (2001) 411-420
30. Burns J.K. An evolutionary theory of schizophrenia: cortical connectivity, metarepresentation, and the social brain. Behav. Brain Sci. 27 (2004) 831-855
31. Cai Z., Pan Z.L., Pang Y., Evans O.B., and Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 47 (2000) 64-72
32. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 159 (2002) 1080-1092
33. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1 (1988) 179-186
34. Carlsson M., and Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome?. Schizophr. Bull. 16 (1990) 425-432
35. Casper D., Mytilineou C., and Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J. Neurosci. Res. 30 (1991) 372-381
36. Chiavetto L.B., Boin F., Zanardini R., Popoli M., Michelato A., Bignotti S., Tura G.B., and Gennarelli M. Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia. Biol. Psychiatry 51 (2002) 480-484
37. Cox S.M., Casey M.L., and MacDonald P.C. Accumulation of interleukin-1beta and interleukin-6 in amniotic fluid: a sequela of labour at term and preterm. Hum. Reprod. Update 3 (1997) 517-527
38. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Ruslanova I., and Yolken R.H. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch. Gen. Psychiatry 60 (2003) 466-472
39. El-Khodor B.F., and Boksa P. Birth insult increases amphetamine-induced behavioral responses in the adult rat. Neuroscience 87 (1998) 893-904
40. El-Khodor B., and Boksa P. Caesarean section birth produces long term changes in dopamine D1 receptors and in stress-induced regulation of D3 and D4 receptors in the rat brain. Neuropsychopharmacology 25 (2001) 423-439
41. Engel J.A., Zhang J., Bergstrom T., Conradi N., Forkstam C., Liljeroth A., and Svensson L. Neonatal herpes simplex virus type 1 brain infection affects the development of sensorimotor gating in rats. Brain Res. 863 (2000) 233-240
42. Falkai P., Honer W.G., David S., Bogerts B., Majtenyi C., and Bayer T.A. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol. Appl. Neurobiol. 25 (1999) 48-53
43. Farina L., and Winkelman C. A review of the role of proinflammatory cytokines in labor and noninfectious preterm labor. Biol. Res. Nurs. 6 (2005) 230-238
44. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., Shier A., Sheikh S., and Bailey K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry 4 (1999) 145-154
45. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., Shi L., and Sidwell R. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol. Neurobiol. 22 (2002) 25-33
46. Feng Y., and LeBlanc M.H. Effect of agmatine on the time course of brain inflammatory cytokines after injury in rat pups. Ann. N.Y. Acad. Sci. 1009 (2003) 152-156
47. Ferrari G., Toffano G., and Skaper S.D. Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: comparison with basic fibroblast growth factor. J. Neurosci. Res. 30 (1991) 493-497
48. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., and Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247 (1997) 228-233
49. Futamura T., Toyooka K., Iritani S., Niizato K., Nakamura R., Tsuchiya K., Someya T., Kakita A., Takahashi H., and Nawa H. Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol. Psychiatry 7 (2002) 673-682
50. Futamura T., Kakita A., Tohmi M., Sotoyama H., Takahashi H., and Nawa H. Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol. Psychiatry 8 (2003) 19-29
51. Ganguli R., Yang Z., Shurin G., Chengappa K.N., Brar J.S., Gubbi A.V., and Rabin B.S. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res. 51 (1994) 1-10
52. Gayle D.A., Beloosesky R., Desai M., Amidi F., Nunez S.E., and Ross M.G. Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R1024-R1029
53. Geddes J.R., Verdoux H., Takei N., Lawrie S.M., Bovet P., Eagles J.M., Heun R., McCreadie R.G., McNeil T.F., O'Callaghan E., Stober G., Willinger U., and Murray R.M. Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr. Bull. 25 (1999) 413-423
54. Geyer M.A., McIlwain K.L., and Paylor R. Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry 7 (2002) 1039-1053
55. Gilmore J.H., and Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr. Res. 24 (1997) 365-367
56. Giulian D., and Lachman L.B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228 (1985) 497-499
57. Haga S., Motoi Y., and Ikeda K. Borna disease virus and neuropsychiatric disorders. The Japan Bornavirus Study Group. Lancet 350 (1997) 592-593
58. Halgunset J., Johnsen H., Kjollesdal A.M., Qvigstad E., Espevik T., and Austgulen R. Cytokine levels in amniotic fluid and inflammatory changes in the placenta from normal deliveries at term. Eur. J. Obstet. Gynecol. Reprod. Biol. 56 (1994) 153-160
59. Harrison P.J. Schizophrenia: a disorder of neurodevelopment?. Curr. Opin. Neurobiol. 7 (1997) 285-289
60. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
61. Hashimoto R., Yoshida M., Ozaki N., Yamanouchi Y., Iwata N., Suzuki T., Kitajima T., Tatsumi M., Kamijima K., and Kunugi H. Association analysis of the -308G>A promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia. J. Neural. Transm. 111 (2004) 217-221
62. Hobbs R.M., and Watt F.M. Regulation of interleukin-1alpha expression by integrins and epidermal growth factor receptor in keratinocytes from a mouse model of inflammatory skin disease. J. Biol. Chem. 278 (2003) 19798-19807
63. Hofmann G.E., and Abramowicz J.S. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet. Gynecol. Scand. 69 (1990) 217-221
64. Hornig M., Weissenbock H., Horscroft N., and Lipkin W.I. An infection-based model of neurodevelopmental damage. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12102-12107
65. Ingvar D.H., and Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr. Scand. 50 (1974) 425-462
66. Iwahashi K., Watanabe M., Nakamura K., Suwaki H., Nakaya T., Nakamura Y., Takahashi H., and Ikuta K. Clinical investigation of the relationship between Borna disease virus (BDV) infection and schizophrenia in 67 patients in Japan. Acta Psychiatr. Scand. 96 (1997) 412-415
67. Iwakura Y., Piao Y.S., Mizuno M., Takei N., Kakita A., Takahashi H., and Nawa H. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. J. Neurochem. 93 (2005) 974-983
68. Iwata N., Suzuki T., Ikeda M., Kitajima T., Yamanouchi Y., Inada T., and Ozaki N. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol. Psychiatry 9 (2004) 126-127
69. Izumoto Y., Inoue S., and Yasuda N. Schizophrenia and the influenza epidemics of 1957 in Japan. Biol. Psychiatry 46 (1999) 119-124
70. Jakob H., and Beckmann H. Gross and histological criteria for developmental disorders in brains of schizophrenics. J. R. Soc. Med. 82 (1989) 466-469
71. Jentsch J.D., Tran A., Le D., Youngren K.D., and Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17 (1997) 92-99
72. Katila H., Appelberg B., Hurme M., and Rimon R. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr. Res. 12 (1994) 29-34
73. Katila H., Hanninen K., and Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol. Psychiatry 4 (1999) 179-181
74. Kendell R.E., and Kemp I.W. Maternal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 46 (1989) 878-882
75. Kim J.S., Kornhuber H.H., Schmid-Burgk W., and Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20 (1980) 379-382
76. Koenig J.I., Kirkpatrick B., and Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27 (2002) 309-318
77. Koenig J.I., Elmer G.I., Shepard P.D., Lee P.R., Mayo C., Joy B., Hercher E., and Brady D.L. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav. Brain Res. 156 (2005) 251-261
78. Kohlhauser C., Mosgoller W., Hoger H., and Lubec B. Myelination deficits in brain of rats following perinatal asphyxia. Life Sci. 67 (2000) 2355-2368
79. Konsman J.P., Parnet P., and Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25 (2002) 154-159
80. Koran L.M. gamma-Aminobutyric-acid deficiency in schizophrenia. Lancet 2 (1976) 1025
81. Kronfol Z., and Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 157 (2000) 683-694
82. Kudelova M., Rajcani J., Pogady J., and Sramka M. Herpes simplex virus DNA in the brain of psychotic patients. Acta Virol. 32 (1988) 455-460
83. Kumari V., Aasen I., and Sharma T. Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr. Res. 69 (2004) 219-235
84. Kunugi H., Nanko S., Takei N., Saito K., Hayashi N., and Kazamatsuri H. Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan. Am. J. Psychiatry 152 (1995) 450-452
85. Kunugi H., Nanko S., Takei N., Saito K., Murray R.M., and Hirose T. Perinatal complications and schizophrenia. Data from the Maternal and Child Health Handbook in Japan. J. Nerv. Ment. Dis. 184 (1996) 542-546
86. Kunugi H., Nanko S., and Murray R.M. Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br. J. Psychiatry Suppl. 40 (2001) s25-s29
87. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6 (2005) 312-324
88. Li Y., Liu L., Barger S.W., and Griffin W.S. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23 (2003) 1605-1611
89. Liberman R.P., and Corrigan P.W. Is schizophrenia a neurological disorder?. J. Neuropsychiatry Clin. Neurosci. 4 (1992) 119-124
90. Licinio J., Seibyl J.P., Altemus M., Charney D.S., and Krystal J.H. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am. J. Psychiatry 150 (1993) 1408-1410
91. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4 (1999) 317-327
92. Lieberman J.A., Sheitman B.B., and Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17 (1997) 205-229
93. Lin A., Kenis G., Bignotti S., Tura G.J., De Jong R., Bosmans E., Pioli R., Altamura C., Scharpe S., and Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32 (1998) 9-15
94. Lipska B.K., Jaskiw G.E., and Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9 (1993) 67-75
95. Lipska B.K., and Weinberger D.R. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 10 (1994) 199-205
96. Lipska B.K., and Weinberger D.R. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8906-89010
97. Lipska B.K., Aultman J.M., Verma A., Weinberger D.R., and Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27 (2002) 47-54
98. Lu Z.W., Song C., Ravindran A.V., Merali Z., and Anisman H. Influence of a psychogenic and a neurogenic stressor on several indices of immune functioning in different strains of mice. Brain Behav. Immun. 12 (1998) 7-22
99. Mallard E.C., Rehn A., Rees S., Tolcos M., and Copolov D. Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophrenia. Schizophr. Res. 40 (1999) 11-21
100. Matsumoto H., Takei N., Saito F., Kachi K., and Mori N. The association between obstetric complications and childhood-onset schizophrenia: a replication study. Psychol. Med. 31 (2001) 907-914
101. Mattoon D.R., Lamothe B., Lax I., and Schlessinger J. The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway. BMC Biol. 2 (2004) 24
102. McAllister C.G., van Kammen D.P., Rehn T.J., Miller A.L., Gurklis J., Kelley M.E., Yao J., and Peters J.L. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am. J. Psychiatry 152 (1995) 1291-1297
103. McClure W.O., Ishtoyan A., and Lyon M. Very mild stress of pregnant rats reduces volume and cell number in nucleus accumbens of adult offspring: some parallels to schizophrenia. Dev. Brain Res. 149 (2004) 21-28
104. McNeil T.F., Cantor-Graae E., and Ismail B. Obstetric complications and congenital malformation in schizophrenia. Brain Res. Rev. 31 (2000) 166-178
105. Mednick S.A., Machon R.A., Huttunen M.O., and Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45 (1988) 189-192
106. Meisenzahl E.M., Rujescu D., Kirner A., Giegling I., Kathmann N., Leinsinger G., Maag K., Hegerl U., Hahn K., and Moller H.J. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am. J. Psychiatry 158 (2001) 1316-1319
107. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29 (2005) 913-947
108. Meyer, U., Schwendener, S, Feldon, J., Yee, B.K., 2006a. Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp. Brain Res., Epub ahead of print.
109. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., and Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain. J. Neurosci. 26 (2006) 4752-4762
110. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav. Immun. 20 (2006) 378-388
111. Mittleman B.B., Castellanos F.X., Jacobsen L.K., Rapoport J.L., Swedo S.E., and Shearer G.M. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J. Immunol. 159 (1997) 2994-2999
112. Mizuno M., Malta Jr. R.S., Nagano T., and Nawa H. Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal period. Ann. N.Y. Acad. Sci. 1025 (2004) 612-618
113. Muller N., and Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatricdisorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 22 (1998) 1-33
114. Munk-Jorgensen P., and Ewald H. Epidemiology in neurobiological research: exemplified by the influenza-schizophrenia theory. Br. J. Psychiatry Suppl. 40 (2001) s30-s32
115. Murray R.M., and Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. Br. Med. J. (Clin. Res. Ed.) 295 (1987) 681-682
116. Namba H., Takei N., and Nawa H. Transforming growth factor-alpha changes firing properties of developing neocortical GABAergic neurons by down-regulation of voltage-gated potassium currents. Neuroscience 122 (2003) 637-646
117. Namba H., Nagano T., Iwakura Y., Xiong H., Jourdi H., Takei N., and Nawa H. Transforming growth factor alpha attenuates the functional expression of AMPA receptors in cortical GABAergic neurons. Mol. Cell Neurosci. 31 (2006) 628-641
118. Nawa H., Takahashi M., and Patterson P.H. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol. Psychiatry 5 (2000) 594-603
119. Noda Y., Yamada K., Furukawa H., and Nabeshima T. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br. J. Pharmacol. 116 (1995) 2531-2537
120. O'Callaghan E., Sham P., Takei N., Glover G., and Murray R.M. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 337 (1991) 1248-1250
121. O'Callaghan E., Gibson T., Colohan H.A., Buckley P., Walshe D.G., Larkin C., and Waddington J.L. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. BMJ 305 (1992) 1256-1259
122. Olney J.W., and Farber N.B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13 (1995) 335-345
123. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., and Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry 59 (2006) 546-554
124. Patel N., Hitzemann B., and Hitzemann R. Genetics, haloperidol, and the Fos response in the basal ganglia: a comparison of the C57BL/6J and DBA/2J inbred mouse strains. Neuropsychopharmacology 18 (1998) 480-491
125. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr. Opin. Neurobiol. 12 (2002) 115-118
126. Prenzel N., Fischer O.M., Streit S., Hart S., and Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr. Relat. Cancer 8 (2001) 11-31
127. Przedborski S., Kostic V., Jackson-Lewis V., Cadet J.L., and Burke R.E. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: a quantitative autoradiographic study. J. Neurochem. 57 (1991) 1951-1961
128. Radewicz K., Garey L.J., Gentleman S.M., and Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 59 (2000) 137-150
129. Romeo R.D., Fossella J.A., Bateup H.S., Sisti H.M., Brake W.G., and McEwen B.S. Maternal separation suppresses TGF alpha mRNA expression in the prefrontal cortex of male and female neonatal C57BL/6 mice. Dev. Brain Res. 152 (2004) 73-77
130. Romero R., Avila C., Santhanam U., and Sehgal P.B. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J. Clin. Invest. 85 (1990) 1392-1400
131. Salvatore M., Morzunov S., Schwemmle M., and Lipkin W.I. Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Bornavirus Study Group. Lancet 349 (1997) 1813-1814
132. Saviouk V., Chow E.W., Bassett A.S., and Brzustowicz L.M. Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44. Mol. Psychiatry 10 (2005) 375-383
133. Scemes E. Components of astrocytic intercellular calcium signaling. Mol. Neurobiol. 22 (2000) 167-179
134. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1 (1987) 133-152
135. Shalev U., Feldon J., and Weiner I. Latent inhibition is disrupted by acute and repeated administration of corticosterone. Int. J. Neuropsychopharmacol. 1 (1998) 103-113
136. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23 (2003) 297-302
137. Shishido Y., Taknaka T., Piao Y.S., Higashiyama S., Takei N., and Nawa H. Behavioral abnormality of the transgenic mice over-expressing HB-EGF. Jpn. Neuochem. Soc. Abstr. (2005) 48
138. Shobokshi A., and Shaarawy M. Maternal serum and amniotic fluid cytokines in patients with preterm premature rupture of membranes with and without intrauterine infection. Int. J. Gynaecol. Obstet. 79 (2002) 209-215
139. Snodgrass-Belt P., Gilbert J.L., and Davis F.C. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters. Brain Res. 1038 (2005) 171-182
140. Solbrig M.V., Koob G.F., Parsons L.H., Kadota T., Horscroft N., Briese T., and Lipkin W.I. Neurotrophic factor expression after CNS viral injury produces enhanced sensitivity to psychostimulants: potential mechanism for addiction vulnerability. J. Neurosci. 20 (2000) 104
141. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., and Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71 (2002) 877-892
142. Stevens J.R. Neuropathology of schizophrenia. Arch. Gen. Psychiatry 39 (1982) 1131-1139
143. Suvisaari J., Haukka J., Tanskanen A., Hovi T., and Lonnqvist J. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am. J. Psychiatry 156 (1999) 1100-1102
144. Swerdlow N.R., and Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24 (1998) 285-301
145. Taieb O., Baleyte J.M., Mazet P., and Fillet A.M. Borna disease virus and psychiatry. Eur. Psychiatry 16 (2001) 3-10
146. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T., and Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 5 (2000) 293-300
147. Takei N., Lewis S., Jones P., Harvey I., and Murray R.M. Prenatal exposure to influenza and increased cerebrospinal fluid spaces in schizophrenia. Schizophr. Bull. 22 (1996) 521-534
148. Takei N., Sham P., O'Callaghan E., Murray G.K., Glover G., and Murray R.M. Prenatal exposure to influenza and the development of schizophrenia: is the effect confined to females?. Am. J. Psychiatry 151 (1994) 117-119
149. Tanaka K.F., Shintani F., Fujii Y., Yagi G., and Asai M. Serum interleukin-18 levels are elevated in schizophrenia. Psychiatry Res. 96 (2000) 75-80
150. Tchelingerian J.L., Le Saux F., and Jacque C. Identification and topography of neuronal cell populations expressing TNF alpha and IL-1 alpha in response to hippocampal lesion. J. Neurosci. Res. 43 (1996) 99-106
151. Tohmi M., Tsuda N., Watanabe Y., Kakita A., and Nawa H. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin. Neurosci. Res. 50 (2004) 67-75
152. Tohmi M., Tsuda N., Mizuno M., Takei N., Frankland P.W., and Nawa H. Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains. Behav. Genet. 35 (2005) 615-629
153. Tokita Y., Keino H., Matsui F., Aono S., Ishiguro H., Higashiyama S., and Oohira A. Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. J. Neurosci. 21 (2001) 1257-1264
154. Torrey E.F., Rawlings R., and Waldman I.N. Schizophrenic births and viral diseases in two states. Schizophr. Res. 1 (1988) 73-77
155. Toyooka K., Watanabe Y., Iritani S., Shimizu E., Iyo M., Nakamura R., Asama K., Makifuchi T., Kakita A., Takahashi H., Someya T., and Nawa H. A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients. Neurosci. Res. 46 (2003) 299-307
156. Tsai G., and Coyle J.T. Glutamatergic mechanisms in schizophrenia. Ann. Rev. Pharmacol. Toxicol. 42 (2002) 165-179
157. Tsuda N., Tohmi M., Mizuno M., and Nawa H. Strain-dependent behavioral alterations induced by peripheral interleukin-1 challenge in neonatal mice. Behav. Brain Res. 166 (2006) 19-31
158. Tsunoda H., Tamatani T., Oomoto Y., Hirai Y., Kasahara T., Iwasaki H., and Onozaki K. Changes in interleukin 1 levels in human amniotic fluid with gestational ages and delivery. Microbiol. Immunol. 34 (1990) 377-385
159. Urakubo A., Jarskog L.F., Lieberman J.A., and Gilmore J.H. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr. Res. 47 (2001) 27-36
160. van Os J., and Selten J.P. Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Br. J. Psychiatry 172 (1998) 324-326
161. Varner M.W., Dildy G.A., Hunter C., Dudley D.J., Clark S.L., and Mitchell M.D. Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies. J. Soc. Gynecol. Investig. 3 (1996) 17-19
162. Virgintino D., Maiorano E., Errede M., Vimercati A., Greco P., Selvaggi L., Roncali L., and Bertossi M. Astroglia-microvessel relationship in the developing human telencephalon. Int. J. Dev. Biol. 42 (1998) 1165-1168
163. Volodin N.N., Chekhonin V.P., Tabolin V.A., Rogatkin S.O., and Kashparov I.A. Status of the blood-brain barrier in newborn infants of various gestational ages in the normal state and in pathology. Pediatriia 3 (1989) 10-14
164. Watanabe M., Lee B.J., Yamashita M., Kamitani W., Kobayashi T., Tomonaga K., and Ikuta K. Borna disease virus induces acute fatal neurological disorders in neonatal gerbils without virus- and immune-mediated cell destructions. Virology 310 (2003) 245-253
165. Watanabe Y., Hashimoto S., Kakita A., Takahashi H., Ko J., Mizuno M., Someya T., Patterson P.H., and Nawa H. Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats. Neurosci. Res. 48 (2004) 345-353
166. Watanabe Y., Fukui N., Muratake T., Kaneko N., and Someya T. No association of EGF polymorphism with schizophrenia in a Japanese population. Neuroreport 16 (2005) 403-405
167. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44 (1987) 660-669
168. Weinberger D.R., and Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 16 (1995) 87-110
169. Weiss I.C., and Feldon J. Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology (Berl.) 156 (2001) 305-326
170. Witkin S.S., Vardhana S., Yih M., Doh K., Bongiovanni A.M., and Gerber S. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome. Am. J. Obstet. Gynecol. 189 (2003) 1413-1417
171. Wolkin A., Jaeger J., Brodie J.D., Wolf A.P., Fowler J., Rotrosen J., Gomez-Mont F., and Cancro R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am. J. Psychiatry 142 (1985) 564-571
172. Yang J.Z., Si T.M., Ruan Y., Ling Y.S., Han Y.H., Wang X.L., Zhou M., Zhang H.Y., Kong Q.M., Liu C., Zhang D.R., Yu Y.Q., Liu S.Z., Ju G.Z., Shu L., Ma D.L., and Zhang D. Association study of neuregulin 1 gene with schizophrenia. Mol. Psychiatry 8 (2003) 706-709
173. Yokomaku D., Jourdi H., Kakita A., Nagano T., Takahashi H., Takei N., and Nawa H. ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins, GRIP1 and SAP97, in developing neocortex. Neuroscience 136 (2005) 490-497
174. Yoon B.H., Jun J.K., Romero R., Park K.H., Gomez R., Choi J.H., and Kim I.O. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am. J. Obstet. Gynecol. 177 (1997) 19-26
175. Zornberg G.L., Buka S.L., and Tsuang M.T. Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am. J. Psychiatry 157 (2000) 196-202
176. Zornberg G.L., Buka S.L., and Tsuang M.T. The problem of obstetrical complications and schizophrenia. Schizophr. Bull. 26 (2000) 249-256
177. Zubin J., and Spring B. Vulnerability-a new view of schizophrenia. J. Abnorm. Psychol. 86 (1977) 103-126
178. Zuckerman L., Rehavi M., Nachman R., and Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28 (2003) 1778-1789